The invention relates to compounds of formula (Ic)
processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
New ubiquinone and ubiquinol analogs are disclosed, as well as methods of making and using these compounds.
本发明揭示了新的泛醌和泛醌醇类似物,以及制备和使用这些化合物的方法。
US7282497B2
申请人:——
公开号:US7282497B2
公开(公告)日:2007-10-16
[EN] NEW UBIQUINONE ANALOGS AND METHODS OF USE<br/>[FR] NOUVEAUX ANALOGUES DE L'UBIQUINONE ET MÉTHODES D'UTILISATION
申请人:UNIV CALIFORNIA
公开号:WO2007095630A2
公开(公告)日:2007-08-23
[EN] New ubiquinone and ubiquinol analogs are disclosed, as well as methods of making and using these compounds. [FR] L'invention concerne de nouveaux analogues de l'ubiquinone et de l'ubiquinol, ainsi que des méthodes de fabrication et d'utilisation de ces composés.
[EN] NEW DRUG DELIVERY SYSTEM FOR CROSSING THE BLOOD BRAIN BARRIER<br/>[FR] NOUVEAU DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT POUR TRAVERSER LA BARRIÈRE HÉMATOMÉNINGÉE
申请人:UNIV CALIFORNIA
公开号:WO2007095631A2
公开(公告)日:2007-08-23
[EN] New ubiquinol analogs are disclosed, as well as methods of using these compounds to deliver drug moieties to the body. [FR] L'invention concerne de nouveaux analogues de l'ubiquinol, ainsi que des méthodes pour utiliser ces composés afin d'administrer des fractions de médicament au corps.